tiprankstipranks
ADMA Biologics (ADMA)
NASDAQ:ADMA
US Market

ADMA Biologics Financial Overview

ADMA Biologics's market cap is currently ―. The company's EPS TTM is $0.276; its P/E ratio is ―; ADMA Biologics is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $0.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit$ 88.94M$ 35.27M$ 1.17M$ -19.07M$ -10.16M
Operating Income$ 21.63M$ -39.37M$ -58.37M$ -64.91M$ -41.42M
EBITDA$ 5.12M$ -39.51M$ -53.09M$ -59.82M$ -45.26M
Net Income$ -28.24M$ -65.90M$ -71.65M$ -75.75M$ -48.28M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 329.18M$ 348.46M$ 276.22M$ 207.64M$ 127.09M
Total Debt$ 141.42M$ 154.44M$ 102.92M$ 97.67M$ 83.43M
Net Debt$ 90.07M$ 67.92M$ 51.83M$ 41.75M$ 56.68M
Total Liabilities$ 193.98M$ 196.49M$ 135.08M$ 119.42M$ 100.90M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ 3.82M$ -73.42M$ -125.88M$ -114.73M$ -82.77M
Operating Cash Flow$ 8.80M$ -59.51M$ -112.37M$ -102.00M$ -78.95M
Investing Cash Flow
Financing Cash Flow
Currency in USD

ADMA Biologics Earnings and Revenue History

ADMA Biologics Debt to Assets

ADMA Biologics Cash Flow

ADMA Biologics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis